Vaccine Development
The CDC suggests the HPV vaccine for all guys ages 11 to 12 and those to age 21 who have not had each of the three measurements of the immunization. It is additionally prescribed for gay, swinger, and men who have intercourse with men. Men through age 26 who are immunocompromised, including HIV positive, who have not had every one of the three dosages may likewise profit. The vaccine is best when given to more youthful guys. The vaccine has been demonstrated to forestall genital warts and anal cancers in guys and may counteract diseases of the oropharynx and penis (ACIP, 2014).
- Classes of drugs and mechanism
- Immunology and strategies towards HIV and retroviral infections
- HIV/AIDS and STDs/STIs: Vaccines research and development
- Nucleoside analogues and molecular mechanisms
- HIV: Current pharmaceutical design
Related Conference of Vaccine Development
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergic Diseases and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Vaccine Development Conference Speakers
Recommended Sessions
- Advanced Techniques involved in STDs
- AIDS stigma and discrimination
- Emerging Technologies towards HIV/AIDS
- Global Epidemiology of HIV/AIDS, STDs, & STIs
- HIV & aging
- HIV in women
- HIV Infection
- HIV Prevention, Treatment & Cure
- HIV Related Infections, Co-Infections and Cancers
- HIV/AIDS, STDs & STIs
- Immunology of HIV/AIDS, STDs & STIs
- knowledge on HIV/AIDS, STDs and STIs
- Lived experience of HIV
- Outbreaks- HIV/AIDS, STDs & STIs
- STD symptoms
- Vaccine Development
- Viral, Bacterial, Fungal & Protozoan STDs
Related Journals
Are you interested in
- Advances in Molecular Immunology - Allergic Conference 2024 (France)
- Allergen Identification and Characterization - Allergic Conference 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - Allergic Conference 2024 (France)
- Case Studies in Allergy Diagnosis and Management - Allergic Conference 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - Allergic Conference 2024 (France)
- Digital Health and Telemedicine in Allergy Care - Allergic Conference 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - Allergic Conference 2024 (France)
- Immune Responses to Vaccination - Allergic Conference 2024 (France)
- Immunogenetics and Allergic Susceptibility - Allergic Conference 2024 (France)
- Immunological Aspects of Drug Allergies - Allergic Conference 2024 (France)
- Immunological Basis of Food Allergy - Allergic Conference 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - Allergic Conference 2024 (France)
- Immunomodulation in Allergy Management - Allergic Conference 2024 (France)
- Immunopathogenesis of Allergic Diseases - Allergic Conference 2024 (France)
- Immunotherapy for Allergic Conditions - Allergic Conference 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - Allergic Conference 2024 (France)
- Mechanisms of Immunodeficiency Diseases - Allergic Conference 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - Allergic Conference 2024 (France)
- Role of Microbiota in Allergic Disorders - Allergic Conference 2024 (France)